tiprankstipranks
Fennec Pharmaceuticals (TSE:FRX)
NASDAQ:FRX
Want to see TSE:FRX full AI Analyst Report?

Fennec Pharmaceuticals (FRX) Revenue

39 Followers

Fennec Pharmaceuticals Revenue

Fennec Pharmaceuticals had a revenue of 15.07M in the quarter ending Mar 31, 2026, with 7.72%. This bring the company's revenue in the last twelve months to 51.17M, Decreased 14.09%. In the fiscal year ending Dec 31, 2025, Fennec Pharmaceuticals had annual revenue of 45.42M with -4.45% growth.
Revenue (ttm)
51.17M
Revenue Growth
63.54%
P/S Ratio
9.50
Revenue/Employee
C$1,419,484
Employees
32
Market Cap
C$431.31M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
45.42M-2.11M-4.45%
Dec 31, 2024
47.54M26.29M+123.69%
Dec 31, 2023
21.25M19.72M+1,284.50%
Dec 31, 2022
1.53M+∞%
Dec 31, 2021
-170.00K-100.00%
Dec 31, 2020
170.00K+∞%
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017